These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 27986595)
1. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity. Chen PH; Shen WL; Shih CM; Ho KH; Cheng CH; Lin CW; Lee CC; Liu AJ; Chen KC Neuropharmacology; 2017 Apr; 116():300-314. PubMed ID: 27986595 [TBL] [Abstract][Full Text] [Related]
2. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death. Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811 [TBL] [Abstract][Full Text] [Related]
3. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM. Tomicic MT; Meise R; Aasland D; Berte N; Kitzinger R; Krämer OH; Kaina B; Christmann M Oncotarget; 2015 Oct; 6(32):33755-68. PubMed ID: 26418950 [TBL] [Abstract][Full Text] [Related]
5. Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway. Chio CC; Tai YT; Mohanraj M; Liu SH; Yang ST; Chen RM Phytomedicine; 2018 Oct; 49():41-51. PubMed ID: 30217261 [TBL] [Abstract][Full Text] [Related]
6. Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells. Hori YS; Hosoda R; Akiyama Y; Sebori R; Wanibuchi M; Mikami T; Sugino T; Suzuki K; Maruyama M; Tsukamoto M; Mikuni N; Horio Y; Kuno A J Neurooncol; 2015 Mar; 122(1):11-20. PubMed ID: 25528635 [TBL] [Abstract][Full Text] [Related]
7. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species. Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells. Lin CJ; Lee CC; Shih YL; Lin CH; Wang SH; Chen TH; Shih CM PLoS One; 2012; 7(6):e38706. PubMed ID: 22745676 [TBL] [Abstract][Full Text] [Related]
9. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381 [TBL] [Abstract][Full Text] [Related]
10. Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells. Oliveira KA; Dal-Cim TA; Lopes FG; Nedel CB; Tasca CI Purinergic Signal; 2017 Sep; 13(3):305-318. PubMed ID: 28536931 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression. Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells. Ohba S; Hirose Y; Kawase T; Sano H J Neurooncol; 2009 Dec; 95(3):307-316. PubMed ID: 19517066 [TBL] [Abstract][Full Text] [Related]
13. Temozolomide induces the expression of the glioma Big Potassium (gBK) ion channel, while inhibiting fascin-1 expression: possible targets for glioma therapy. Hoa NT; Ge L; Martini F; Chau V; Ahluwalia A; Kruse CA; Jadus MR Expert Opin Ther Targets; 2016 Oct; 20(10):1155-67. PubMed ID: 27359377 [TBL] [Abstract][Full Text] [Related]
14. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539 [TBL] [Abstract][Full Text] [Related]
15. Augmentation of invadopodia formation in temozolomide-resistant or adopted glioma is regulated by c-Jun terminal kinase-paxillin axis. Ueno H; Tomiyama A; Yamaguchi H; Uekita T; Shirakihara T; Nakashima K; Otani N; Wada K; Sakai R; Arai H; Mori K Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):240-7. PubMed ID: 26518652 [TBL] [Abstract][Full Text] [Related]
16. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Kanzawa T; Germano IM; Komata T; Ito H; Kondo Y; Kondo S Cell Death Differ; 2004 Apr; 11(4):448-57. PubMed ID: 14713959 [TBL] [Abstract][Full Text] [Related]
17. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells. Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224 [TBL] [Abstract][Full Text] [Related]
19. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways. Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789 [TBL] [Abstract][Full Text] [Related]
20. The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death. Chen PH; Chang CK; Shih CM; Cheng CH; Lin CW; Lee CC; Liu AJ; Ho KH; Chen KC Neuropharmacology; 2016 Nov; 110(Pt A):362-375. PubMed ID: 27487563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]